Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results

Go back to Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results
(NASDAQ: CRNX) Delayed: 83.65 -0.07 (0.08%)
Previous Close $83.72    52 Week High
Open $83.78    52 Week Low
Day High $83.79    P/E N/A 
Day Low $83.64    EPS
Volume 4,268,878